Korro Bio Inc
(KRRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 11,247 | 8,523 | 7,264 | 4,709 | 24,238 |
| Gross Profit | 11,247 | 8,523 | 7,264 | 4,709 | 24,238 |
| Operating Expenses | 16,665 | 14,723 | 12,919 | 11,197 | 25,490 |
| Operating Income | -5,418 | -6,200 | -5,655 | -6,488 | -1,252 |
| Other Income | 92 | 182 | 780 | 995 | 677 |
| Pre-tax Income | -5,326 | -6,018 | -4,875 | -5,493 | -575 |
| Income Tax | 15 | 7 | 38 | N/A | N/A |
| Net Income Continuous | -5,341 | -6,025 | -4,913 | -5,493 | -575 |
| Net Income | $-5,341 | $-6,025 | $-4,913 | $-5,493 | $-575 |
| EPS Basic Total Ops | -8.00 | -9.50 | -8.00 | 255.00 | -36.50 |
| EPS Basic Continuous Ops | -8.07 | -9.70 | -7.96 | 237.38 | -13.29 |
| EPS Diluted Total Ops | -8.00 | -9.50 | -8.00 | 255.00 | -36.50 |
| EPS Diluted Continuous Ops | -8.07 | -9.70 | -7.96 | 237.38 | -13.29 |
| EBITDA(a) | $-5,117 | $-5,956 | $-5,440 | $-6,263 | $-1,038 |